Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline    GS7   GB0009252882

GLAXOSMITHKLINE (GS7)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline
Develops, manufactures and distributes vaccines and other pharmaceutical products

‘GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products.

It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Emma Walmsley-2010Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans542011Chief Financial Officer & Executive Director
Patrick J. T. Vallance, MD-2006Executive Director, President-R&D
Karenann K. Terrell552017Chief Technology Officer
Roy Malcolm Anderson692007Independent Non-Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Lynn Laverty Elsenhans, MBA612012Independent Non-Executive Director
Urs Rohner582015Independent Non-Executive Director
Manvinder Singh Banga622015Senior Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,371,887,664 4,862,263,103 90.5% 453,205,950 8.4% 90.5%
Shareholders
NameEquities%
The Vanguard Group, Inc. 140,163,540 2.85%
BlackRock Investment Management (UK) Ltd. 137,165,476 2.79%
Legal & General Investment Management Ltd. 108,700,954 2.21%
Norges Bank Investment Management 104,846,000 2.13%
BlackRock Advisors (UK) Ltd. 88,133,021 1.79%
BlackRock Fund Advisors 64,609,000 1.31%
State Street Global Advisors Ltd. 63,131,913 1.28%
Threadneedle Asset Management Ltd. 59,029,931 1.20%
Schroder Investment Management Ltd. 58,061,098 1.18%
Capital Research & Management Co. (World Investors) 57,263,010 1.16%
Holdings
NameEquities%Valuation
Innoviva Inc (INVA) 32,005,26029.6%391,744,382 USD
Theravance Biopharma Inc (TBPH) 9,644,80717.9%278,349,130 USD
Crispr Therapeutics AG (CRSP) 3,220,6277.93%62,158,101 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%56,354,088 USD
Dong-A ST Co Ltd (170900) 693,9808.22%55,377,168 USD
ChemoCentryx Inc (CCXI) 7,343,49215.1%48,246,742 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.67%44,613,331 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5466.93%10,508,410 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%4,568,277 USD
HTG Molecular Diagnostics Inc (HTGM) 749,2436.54%1,678,304 USD
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
Company contact information
GlaxoSmithKline
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE-18.79%85 349
JOHNSON & JOHNSON20.08%368 832
NOVARTIS12.75%219 874
ROCHE HOLDING LTD.4.90%215 394
PFIZER9.42%211 188
MERCK AND COMPANY-7.64%148 286
AMGEN16.16%123 376
SANOFI-0.25%114 646
BAYER9.45%106 161
NOVO NORDISK A/S29.01%102 274
BRISTOL-MYERS SQUIBB COMPANY4.79%100 068
ABBOTT LABORATORIES45.27%97 126
ELI LILLY AND COMPANY13.54%92 140
GLAXOSMITHKLINE-16.61%85 349
ASTRAZENECA12.83%83 904
CELGENE CORPORATION-9.72%82 794
ALLERGAN PLC-18.73%58 146
SHIRE-19.90%45 128
TAKEDA PHARMACEUTICAL CO LTD27.30%43 754
JIANGSU HENGRUI MEDICINE CO LTD52.11%29 368
CHUGAI PHARMACEUTICAL CO LTD67.51%28 271
Connections : GlaxoSmithKline
The Institute of International Finance, Inc.
Office for Strategic Co-ordination of Health Research
International Institute for Management Development
UK Biobank Ltd.
High Ridge Brands Co.
Purdue University
Alfred Escher-Stiftung
The New York Hall of Science
Zurich Bar Association
The Natural History Museum
Institute of Medicine
Genome Research Ltd.
French Academy of Sciences
Opernhaus Zürich AG
Pearson Education Ltd.
Economiesuisse
National Theatre of Scotland
Swiss Finance Council
Smithkline Beecham Ltd.
Mauser Group NV
Rockefeller Family Trust, Inc.
Confederation of British Industry
American Academy of Arts & Sciences
The Indus Entrepreneurs (Delhi)
Massachusetts Institute of Technology
Zurich Chamber of Commerce
Sunoco Chemicals, Inc.
Institute International d'Etudes Bancaires
Sunoco Partners LLC
Lucerne Festival
United Way of Greater Houston
Avenir Suisse
Rice University
IMD Scholarship Foundation
World Golf Foundation, Inc.
Swiss Bankers Association
The Texas Medical Center
New York State Bar Association
Central Houston, Inc.
European Financial Services Round Table
Diversey, Inc.
The First Tee of Greater Houston
The 100 Group
Indian Institute of Management
The Council for Industry & Higher Education
Kedaara Capital I Ltd.
Credit Suisse AG
World Presidents' Organization
Credit Suisse Americas Foundation
Indian School of Business
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem